everything.study
HST.161

Genetics in Modern Medicine

2-0-4 units · Graduate

Provides a foundation for understanding the relationship between molecular biology, genetics, and medicine. Starts with an introduction to molecular genetics, and quickly transitions to the genetic basis of diseases, including chromosomal, mitochondrial and epigenetic disease. Translation of clinical understanding into analysis at the level of the gene, chromosome, and molecule; the concepts and techniques of molecular biology and genomics; and the strategies and methods of genetic analysis. Includes diagnostics (prenatal and adult), cancer genetics, and the development of genetic therapies (RNA, viral, and genome editing). The clinical relevance of these areas is underscored with patient presentations. Only HST students may register under HST.160 , graded P/D/F.

Fall 2007 · Molecular Biology and Genetics in Modern Medicine

This course provides a foundation for understanding the relationship between molecular biology, developmental biology, genetics, genomics, bioinformatics, and medicine. It develops explicit connections between basic research, medical understanding, and the perspective of patients. Principles of human genetics are reviewed. We translate clinical understanding into analysis at the level of the gene, chromosome and molecule; we cover the concepts and techniques of molecular biology and genomics, and the strategies and methods of genetic analysis, including an introduction to bioinformatics. Material in the course extends beyond basic principles to current research activity in human genetics.

Readings

  • Binder, William D., Michael A. Fifer, Mary Etta King, and James R. Stone. “Case 26-2005: A 48-Year-Old Man with Sudden Loss of Consciousness while Jogging.” N Engl J Med 353 (2005): 824-832.
    Recommended
  • Brown, Robert H., D. Phil, P. Ellen Grant, and Christopher R. Pierson. “Case 35-2006: A Newborn Boy with Hypotonia.” N Engl J Med 355 (2006): 2132-2142.
    Recommended
  • Walton, David S., Shizuo Mukai, Eric F. Grabowski, John E. Munzenrider, and Thaddeus P. Dryja. “Case 5-2006: An 11-Year-Old Girl with Loss of Vision in the Right Eye.” N Engl J Med 354 (2006): 741-748.
    Recommended
  • Stoler, Joan M., Natalia T. Leach, and Patricia K. Donahoe. “Case 36-2004: A 23-Day-Old Infant with Hypospadias and Failure to Thrive.” N Engl J Med 351 (2004): 2319-2326.
    Recommended
  • Blake, Derek J., Andrew Weir, Sarah E. Newey, and Kay E. Davies. “Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle.” Physiol Rev 82 (2002): 291-329.
    Recommended
  • Watkins, Hugh, Ludwig Thierfelder, Ryuichiro Anan, John Jarcho, Akira Matsumori, William McKenna, J. G. Seidman, and Christine E. Seidman. “Independent Origin of Identical? Cardiac Myosin Heavy-Chain Mutations in Hypertrophic Cardiomyopathy.” Am J Hum Genetics 53 (1993): 1180-1185.
    Recommended
  • Morita, Hiroyuki, Jonathan Seidman, and Christine E. Seidman. “Genetic Causes of Human Heart Failure.” J Clin Invest 115 (2005): 518-526.
    Recommended
  • Adler, Elliot, Mark A. Hoon, Ken L. Mueller, Jayaram Chandrashekar, Nicholas J. P. Ryba, and Charles S. Zuker. “A Novel Family of Mammalian Taste Receptors.” Cell 100 (2000): 693-702.
    Listed reading
  • Chandrashekar, Jayaram, Ken L. Mueller, Mark A. Hoon, Elliot Adler, Luxin Feng, Wei Guo, Charles S. Zuker, and Nicholas J. P. Ryba. “T2Rs Function as Bitter Taste Receptors.” Cell 100 (2000): 703-711.
    Listed reading
  • Allamand, Valerie, et al. “A Single Homozygous Point Mutation in a 3’ Untranslated Region Motif of Selenoprotein N mRNA Causes SEPN1-related Myopathy.” EMBO Reports 7 (2006): 450-454.
    Listed reading
  • Hatfield, Dolph L., and Vadim N. Gladyshev. “How Selenium Has Altered Our Understanding of the Genetic Code.” Molec and Cell Bio 22 (2002): 3565-3576.
    Listed reading
  • Moosmann, Bernd, and Christian Behl. “Selenoprotein Synthesis and Side-effects of Statins.” Lancet 363 (2004): 892-894.
    Recommended
  • Baker, Steven K. “Molecular Clues into the Pathogenesis of Statin-mediated Muscle Toxicity.” Muscle & Nerve 31 (2005): 572-580.
    Recommended
  • Maron, Barry J. “Sudden Death in Young Athletes.” N Engl J Med 349 (2003): 1064-1075.
    Recommended
  • Welch, Ellen M., et al. “PTC124 Targets Genetic Disorders Caused by Nonsense Mutations.” Nature 447 (2007): 87-93.
    Listed reading
  • Kuzmiak, Holly A., and Lynne E. Maquat. “Applying Nonsense-mediated mRNA Decay Research to the Clinic: Progress and Challenges.” Trends in Molecular Medicine 12 (2006): 306-316.
    Listed reading
  • Song, Lei, Steven R. DePalma, Maria Kharlap, Andrey G. Zenovich, Allison Cirino, Richard Mitchell, Barbara McDonough, Barry J. Maron, Christine E. Seidman, J. G. Seidman, and Carolyn Y. Ho. “Novel Locus for an Inherited Cardiomyopathy Maps to Chromosome 7.” Circulation 113 (2006): 2186-2192.
    Listed reading
  • Olivieri, Nancy F. “The β-Thalassemias.” N Engl J Med 341 (1999): 99-109.
    Listed reading
  • Min-Oo, Gundula, and Philippe Gros. “Erythrocyte Variants and the Nature of Their Malaria Protective Effect.” Cellular Microbiology 7 (2005): 753-763.
    Listed reading
  • Nachman, Michael W., and Susan L. Crowell. “Estimate of the Mutation Rate per Nucleotide in Humans.” Genetics 156 (2000): 297-304.
    Listed reading
  • Crow, James F. “The Origins, Patterns and Implications of Human Spontaneous Mutation.” Nature Reviews Genetics 1 (2000): 40-47.
    Listed reading
  • Watkins, Hugh, Ludwig Thierfelder, Ryuichiro Anan, John Jarcho, Akira Matsumori, William McKenna, J. G. Seidman, and Christine E. Seidman. “Independent Origin of Identical? Cardiac Myosin Heavy-Chain Mutations in Hypertrophic Cardiomyopathy.” Am J Hum Genetics 53 (1993): 1180-1185.
    Listed reading
  • Koenig, M., et al. “The Molecular Basis for Duchenne versus Becker Muscular Dystrophy: Correlation of Severity with Type of Deletion.” Am J Hum Genet 45 (1989): 498-506.
    Listed reading
  • Liebhaber, S. A., E.-U. Griese, I. Weiss, F. E. Cash, H. Ayyub, D. R. Higgs, and J. Horst. “Inactivation of Human α-globin Gene Expression by a de novo Deletion Located Upstream of the α-globin Gene Cluster.” PNAS 87 (1990): 9431-9435.
    Listed reading
  • Sebat, Jonathan, et al. “Strong Associations of De Novo Copy Number Mutations with Autism.” Science 316 (2007): 445-449.
    Listed reading
  • Iafrate, A. John, Lars Feuk, Miguel N. Rivera, Marc L. Listewnik, Patricia K. Donahoe, Ying Qi, Stephen W. Scherer, and Charles Lee. “Detection of Large-scale Variation in the Human Genome.” Nature Genetics 36 (2004): 949-951.
    Listed reading
  • Crow, James F. “Felix Bernstein and the First Human Marker Locus.” Genetics 133 (1993): 4-7.
    Listed reading
  • Tsakiri, Kalliopi D., et al. “Adult-onset Pulmonary Fibrosis Caused by Mutations in Telomerase.” PNAS 104 (2007): 7552-7557.
    Listed reading
  • Stamm, Christof, Ingeborg Friehs, Siew Yen Ho, Adrian M. Moran, Richard A. Jonas, and Pedro J. del Nido. “Review: Congenital Supravalvar Aortic Stenosis: A Simple Lesion?” European Journal of Cardio-thoracic Surgery 19 (2001): 195-202.
    Listed reading
  • Meyer-Lindenberg, Andreas, Carolyn B. Mervis, and Karen Faith Berman. “Neural Mechanisms in Williams Syndrome: A Unique Window to Genetic Influences on Cognition and Behaviour.” Nature Reviews Neuroscience 7 (2006): 380-393.
    Listed reading
  • Herman, David, Kai Jenssen, Ryan Burnett, Elisabetta Soragni, Susan L Perlman, and Joel M. Gottesfeld. “Histone Deacetylase Inhibitors Reverse Gene Silencing in Friedreich’s Ataxia.” Nature Chemical Biology 2 (2006): 551-558.
    Listed reading
  • Puccio, Helene, and Michel Koenig. “Friedreich Ataxia: A Paradigm for Mitochondrial Diseases.” Current Opinion in Genetics and Development 12 (2202): 272-277.
    Listed reading
  • Bacher, Christian P., Michele Guggiari, Benedikt Brors, Sandrine Augui, Philippe Clerc, Philip Avner, Roland Eils, and Edith Heard. “Transient Colocalization of X-inactivation Centres Accompanies the Initiation of X Inactivation.” Nature Cell Biology 8 (2006): 293-299.
    Listed reading
  • Xu, Na, Chia-Lun Tsai, and Jeannie T. Lee. “Transient Homologous Chromosome Pairing Marks the Onset of X Inactivation.” Science 311 (2006): 1149-1152.
    Listed reading
  • Orr, Harry T., and Huda Y. Zoghbi. “Trinucleotide Repeat Disorders.” Annu Rev Neurosci 30 (2007): 575-621.
    Listed reading
  • Ranum, Laura P. W., and Thomas A. Cooper. “RNA-Mediated Neuromuscular Disorders.” Annu Rev Neurosci 29 (2006): 259-277.
    Recommended
  • Mirkin, Sergei M. “DNA Structures, Repeat Expansions and Human Hereditary Disorders.” Current Opinion in Structural Biology 16 (2006): 351-358.
    Recommended
  • Penagarikano, Olga, Jennifer G. Mulle, and Stephen T. Warren. “The Pathophysiology of Fragile X Syndrome.” Annu Rev Genomics Hum Genet 8 (2007): 109-129.
    Recommended
  • Butler, Rachel, and Gillian P. Bates. “Histone Deacetylase Inhibitors as Therapeutics for Polyglutamine Disorders.” Nature Reviews Neuroscience 7 (2006): 784-796.
    Recommended
  • Imbert, Georges, Christine Kretz, Keith Johnson, and Jean-Louis Mandel. “Original of the Expansion Mutation in Myotonic Dystrophy.” Nature Genetics 4 (1993): 72-76.
    Recommended
  • Bachinski, Linda L., et al. “Confirmation of the Type 2 Myotonic Dystrophy (CCTG)n Expansion Mutation in Patients with Proximal Myotonic Myopathy/Proximal Myotonic Dystrophy of Different European Origins: A Single Shared Haplotype Indicates an Ancestral Founder Effect.” Am J Hum Genet 73 (2003): 835-848.
    Recommended
  • Martorell, L., J. Gamez, M. L. Cayuela, F. K. Gould, J. P. McAbney, T. Ashizawa, D. G. Monckton, and M. Baiget. “Germline Mutational Dynamics in Myotonic Dystrophy Type 1 Males: Allele Length and Age Effects.” Neurology 62 (2004): 269-274.
    Recommended
  • Kanadia, Rahul N., et al. “A Muscleblind Knockout Model for Myotonic Dystrophy.” Science 302 (2003): 1978-1980.
    Recommended
  • Manley, Kevin, Thomas L. Shirley, Lorraine Flaherty, and Anne Messer. “Msh2 Deficiency Prevents in Vivo Somatic Instability of the CAG Repeat in Huntington Disease Transgenic Mice.” Nature Genetics 23 (1999): 471-473.
    Recommended
  • Lin, Xiaoyan, et al. “Failure of MBNL1-dependent Post-natal Splicing Transitions in Myotonic Dystrophy.” Human Molecular Genetics 15 (2006): 2087-2097.
    Recommended
  • McBride, Sean M. J., et al. “Pharmacological Rescue of Synaptic Plasticity, Courtship Behavior, and Mushroom Body Defects in a Drosophila Model of Fragile X Syndrome.” Neuron 45 (2005): 753-764.
    Recommended
  • Hockly, Emma, et al. “Suberoylanilide Hydroxamic Acid, a Histone Deacetylase Inhibitor, Ameliorates Motor Deficits in a Mouse Model of Huntington’s Disease.” PNAS 100 (2003): 2041-2046.
    Recommended
  • Lemmers, Richard J. L. F., et al. “Specific Sequence Variations within the 4q35 Region Are Associated with Facioscapulohumeral Muscular Dystrophy.” Am J Hum Genet 81 (2007): 884-894.
    Listed reading
  • Van der Maarel, Silvere M., and Rune R. Frants. “The D4Z4 Repeat-Mediated Pathogenesis for Facioscapulohumeral Muscular Dystrophy.” Am J Hum Genet 76 (2005): 375-386.
    Listed reading
  • Lemmers, Richard J. L. F., et al. “Facioscapulohumeral Muscular Dystrophy is Uniquely Associated With One of the Two Variants of the 4q Subtelomere.” Nature Genetics 32 (2002): 235-236.
    Listed reading
  • Buiting, Karin, et al. “Epimutations in Prader-Willi and Angelman Syndromes: A Molecular Study of 136 Patients with an Imprinting Defect.” Am J Hum Genet 72 (2003): 571-577.
    Listed reading
  • Horsthemke, B., and K. Buiting. “Imprinting Defects on Human Chromosome 15.” Cytogenet Genome Res 113 (2006): 292-299.
    Listed reading
  • Williamson, Sarah L., and John Christodoulou. “Rett Syndrome: New Clinical and Molecular Insights.” Euro J Hum Genet 14 (2006): 896-903.
    Listed reading
  • Reik, Wolf, and Annabelle Lewis. “Co-evolution of X-chromosome Inactivation and Imprinting in Mammals.” Nature Rev Genetics 1, AOP (2005): 1-8.
    Listed reading
  • Robertson, Keith D. “DNA Methylation and Human Disease.” Nature Rev Genetics 6 (2005): 597-610.
    Listed reading
  • Bell, Daphne W., et al. “Inherited Susceptibility to Lung Cancer may be Associated With the T790M Drug Resistance Mutation in EGFR.” Nature Genetics 37 (2005): 1315-1316.
    Listed reading
  • Engelman, Jeffrey A., et al. “MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling.” Science 316 (2007): 1039-1043.
    Listed reading
  • Cavenee, W. K., et al. “Expression of Recessive Alleles by Chromosomal Mechanisms in Retinoblastoma.” Nature 305 (1983): 779-784.
    Listed reading
  • Klein, Robert J. “Complement Factor H Polymorphism in Age-Related Macular Degeneration.” Science 308 (2005): 385-389.
    Listed reading
  • Strachan, T. Human Molecular Genetics . 3rd ed. New York, NY: Garland Science, 2003. ISBN: 9780815341840.
    Listed reading
  • The textbook will give basic discussion of most topics covered in the course. It should be noted, however, that the level of depth with which most topics will be covered will be greater than in this (or any other) text. Review articles and articles from the primary literature will complement the text.
    Listed reading

Prerequisites & course information

Subject meets with HST.160 Prereq: 7.05 G (Fall; second half of term) 2-0-4 units

Sources